^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CART22

    i
    Associations
    News

    Trials

    Company:
    Academy of Military Medical Sciences
    Drug class:
    CD22-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News

    Trials

    Apply
    Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies (NCT03262298)
    Phase 1/2
    Affiliated Hospital to Academy of Military Medi...
    Recruiting
    Last update posted :
    02/09/2021
    Initiation :
    08/20/2017
    Primary completion :
    08/20/2021
    Completion :
    08/20/2022
    CD22
    |
    CD22 positive
    |
    CART22